Indiva Future Growth
Future criteria checks 2/6
Indiva is forecast to grow revenue at 11.6% per annum. EPS is expected to grow by 105.3% per annum.
Key information
n/a
Earnings growth rate
105.3%
EPS growth rate
| Pharmaceuticals earnings growth | 56.9% |
| Revenue growth rate | 11.6% |
| Future return on equity | 55.9% |
| Analyst coverage | Low |
| Last updated | 04 Jan 2024 |
Recent future growth updates
Recent updates
Indiva Limited (CVE:NDVA) Stock Catapults 33% Though Its Price And Business Still Lag The Industry
Sep 29
Is Indiva (CVE:NDVA) Using Debt In A Risky Way?
Sep 17Is Indiva (CVE:NDVA) A Risky Investment?
Apr 19Is Indiva (CVE:NDVA) Using Too Much Debt?
Feb 26Would Indiva (CVE:NDVA) Be Better Off With Less Debt?
Sep 04Would Indiva (CVE:NDVA) Be Better Off With Less Debt?
Nov 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 46 | N/A | 3 | 1 | 1 |
| 12/31/2024 | 43 | N/A | 3 | 2 | 1 |
| 12/31/2023 | 37 | N/A | 3 | 1 | 1 |
| 9/30/2023 | 36 | -7 | 0 | 1 | N/A |
| 6/30/2023 | 34 | -9 | 0 | 1 | N/A |
| 3/31/2023 | 35 | -10 | 1 | 2 | N/A |
| 12/31/2022 | 34 | -11 | 0 | 2 | N/A |
| 9/30/2022 | 34 | -12 | -10 | -9 | N/A |
| 6/30/2022 | 34 | -16 | -12 | -10 | N/A |
| 3/31/2022 | 35 | -15 | -16 | -14 | N/A |
| 12/31/2021 | 32 | -15 | -20 | -18 | N/A |
| 9/30/2021 | 30 | -18 | -9 | -7 | N/A |
| 6/30/2021 | 25 | -15 | -14 | -12 | N/A |
| 3/31/2021 | 19 | -16 | -11 | -9 | N/A |
| 12/31/2020 | 15 | -15 | -9 | -7 | N/A |
| 9/30/2020 | 8 | -11 | -11 | -11 | N/A |
| 6/30/2020 | 5 | -10 | -10 | -7 | N/A |
| 3/31/2020 | 3 | -10 | -13 | -8 | N/A |
| 12/31/2019 | 1 | -11 | -22 | -10 | N/A |
| 9/30/2019 | 1 | -11 | -23 | -9 | N/A |
| 6/30/2019 | 0 | -10 | -23 | -9 | N/A |
| 3/31/2019 | 0 | -10 | -23 | -11 | N/A |
| 12/31/2018 | 0 | -9 | -14 | -10 | N/A |
| 9/30/2018 | N/A | -7 | -10 | -8 | N/A |
| 6/30/2018 | N/A | -6 | -8 | -7 | N/A |
| 3/31/2018 | N/A | -5 | -4 | -3 | N/A |
| 12/31/2017 | N/A | -3 | -5 | -2 | N/A |
| 9/30/2017 | N/A | -2 | -6 | -2 | N/A |
| 6/30/2017 | N/A | -2 | N/A | -1 | N/A |
| 3/31/2017 | N/A | -1 | N/A | -2 | N/A |
| 12/31/2016 | N/A | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NDVA's forecast earnings growth is above the savings rate (2%).
Earnings vs Market: Insufficient data to determine if NDVA's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if NDVA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: NDVA's revenue (11.6% per year) is forecast to grow faster than the Canadian market (6.6% per year).
High Growth Revenue: NDVA's revenue (11.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NDVA's Return on Equity is forecast to be very high in 3 years time (55.9%).